The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Polymer–drug conjugates: Progress in polymeric prodrugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Synthetic DNA delivery systems
Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/71889 · Cited by 1,626
Abuchowski, A., van Es, T., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094 · cited 1×
“In 1975, a rational model for pharmacologically active polymers was proposed by Ringsdorf—considered to be the pioneer of polymeric prodrug research [15].”
BackgroundPeptide and protein PEGylation
Veronese, F. M. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00193-9 · Cited by 1,067
Transfer of Genes to Humans: Early Lessons and Obstacles to Success
Crystal, R. G. (1995) · Science · doi:10.1126/science.270.5235.404 · Cited by 1,000
Cationic Polymer Based Gene Delivery Systems
De Smedt, S. C., Demeester, J., & Hennink, W. E. (2000) · Pharmaceutical Research · doi:10.1023/a:1007548826495 · Cited by 884
Effective drug delivery by PEGylated drug conjugates
Greenwald, R. B., Choe, Y. H., McGuire, J., & Conover, C. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00180-1 · Cited by 869
Biodegradable polymers as drug delivery systems
(1992) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(92)90663-b · Cited by 779
(1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(97)89864-3 · Cited by 750
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Kopecek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00075-8 · Cited by 562
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
Chemistry of polyethylene glycol conjugates with biologically active molecules
Zalipsky, S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00023-z · Cited by 552
Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini
Putnam, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031577698 · Cited by 510
Polymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494
Dextrans for targeted and sustained delivery of therapeutic and imaging agents
Mehvar, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00302-3 · Cited by 434
Biodegradable Polymers as Drug Delivery Systems
(1991) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049109043830 · Cited by 431
Poly(l-glutamic acid)–anticancer drug conjugates
Li, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00045-5 · Cited by 414
(1990) · PubMed · Cited by 398
Controlled release of bioactive agents from lactide/glycolide polymers
Lewis, D. H. (1990) · Drugs and the pharmaceutical sciences · Cited by 370
Greenwald, R. B. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00331-5 · Cited by 353
Controlled drug delivery : fundamentals and applications
Robinson, J. R., & Lee, V. H. L. (1987) · Medical Entomology and Zoology · Cited by 349
Etrych, T., Jelı́nková, M., Řı́hová, B., & Ulbrich, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00281-4 · Cited by 340
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide
Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein, S., Farmanfarmaian, A., & Minko, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504274102 · Cited by 340
Self-citationPolymeric drugs based on conjugates of synthetic and natural macromolecules
Ulbrich, K., Šubr, V, Strohalm, J., Plocová, D., Jelı́nková, M., & Řı́hová, B. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00141-8 · Cited by 333
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Charrois, G. J. R., & Allen, T. M. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.006 · Cited by 300
Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1026166729873 · Cited by 256
Minko, T., Kopečková, P., Pozharov, V., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00009-1 · Cited by 243
Self-citationToncheva, V., Wolfert, M. A., Dash, P. R., Oupicky, D., Ulbrich, K., Seymour, L. W., & Schacht, E. H. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00004-x · Cited by 243
Controlled drug delivery: Fundamentals and applications
Tyle, P. (1988) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600770119 · Cited by 240
Bourke, S. L., & Kohn, J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00038-3 · Cited by 238
Takakura, Y., & Hashida, M. (1996) · Pharmaceutical Research · doi:10.1023/a:1016084508097 · Cited by 226
Greenwald, R. B., Gilbert, C. W., Pendri, A., Conover, C. D., Xia, J., & Martinez, A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950475e · Cited by 223
Drug targeting to the colon with lectins and neoglycoconjugates
Minko, T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.017 · Cited by 222
Self-citationFang, J., Sawa, T., & Maeda, H. (2005) · Advances in Experimental Medicine and Biology · doi:10.1007/0-306-47932-x_2 · Cited by 221
Deutsch, H. M., Glinski, J. A., Hernandez, M., Haugwitz, R. D., Narayanan, V. L., Suffness, M., & Zalkow, L. H. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00124a011 · Cited by 221
Design of Dendritic Macromolecules Containing Folate or Methotrexate Residues
Kono, K., Liu, M., & Fréchet, J. M. J. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990082k · Cited by 207
HPMA copolymers with pH-controlled release of doxorubicin
Ulbrich, K., Etrych, T., Chytil, P., Jelı́nková, M., & Řı́hová, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00348-6 · Cited by 198
Chau, Y., Tan, F. E., & Langer, R. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499174 · Cited by 187
Preclinical evaluation of polymer-bound doxorubicin
Duncan, R., Seymour, L. W., O'Hare, K. B., Flanagan, P. A., Wedge, S., Hume, I. C., Ulbrich, K., Strohalm, J., Subr, V., Spreafico, F., et al. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90088-9 · Cited by 187
Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid
Wiwattanapatapee, R., Lomlim, L., & Saramunee, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00461-3 · Cited by 178
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
Dharap, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00209-8 · Cited by 172
Hoste, K., De Winne, K., & Schacht, E. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.07.016 · Cited by 165
Polymer Conjugates: Pharmacokinetic Considerations for Design and Development
Duncan, R., & Spreafico, F. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00004 · Cited by 164
Jatzkewitz, H. (1955) · Zeitschrift für Naturforschung B · doi:10.1515/znb-1955-0106 · Cited by 158
Etrych, T., Chytil, P., Jelínková, M., Říhová, B., & Ulbrich, K. (2002) · Macromolecular Bioscience · doi:10.1002/1616-5195(20020101)2:1<43::aid-mabi43>3.0.co;2-8 · Cited by 152
Newkome, G. R., Keith, J. M., Baker, G. R., Escamilla, G. H., & Moorefield, C. N. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199406661 · Cited by 146
Khandare, J. J., Kolhe, P., Pillai, O., Kannan, S., Lieh-Lai, M. W., & Kannan, R. M. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498018 · Cited by 144
Self-citationMinko, T., Paranjpe, P. V., Qiu, B., Lalloo, A., Won, R., Stein, S., & Sinko, P. J. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0463-1 · Cited by 120
Self-citationThe crucial role of spacer groups in macromolecular prodrug design
Soyez, H., Schacht, E. H., & Vanderkerken, S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00400-0 · Cited by 118
David, A., Kopečková, P., Minko, T., Rubinstein, A., & Kopec̆ek, J. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.07.001 · Cited by 113
Self-citationLee, L. S., Conover, C., Shi, C., et al. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990076o · Cited by 113
Kannan, S., Kolhe, P., Raykova, V., Glibatec, M., Kannan, R. M., Lieh-Lai, M. W., & Bassett, D. J. P. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856204322977201 · Cited by 107
Řı́hová, B., Etrych, T., Pechar, M., Jelínková, M., Šťastný, M., Hovorka, O., Kovář, M., & Ulbrich, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00320-0 · Cited by 106
Polymeric anticancer drugs with pH-controlled activation
Ulbrich, K., Etrych, T., Chytil, P., Pechar, M., Jelínková, M., & Rihova, B. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.02.001 · Cited by 103
Duncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopec̆ek, J. (1982) · Bioscience Reports · doi:10.1007/bf01122173 · Cited by 101
Minko, T., Kopečková, P., & Kopec̆ek, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00186-2 · Cited by 97
Self-citationPolymeric drugs based on conjugates of synthetic and natural macromolecules.
Řı́hová, B., Jelínková, M., Strohalm, J., Šubr, V., Plocová, D., Hovorka, O., Novák, M., Plundrová, D., Germano, Y., & Ulbrich, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00140-6 · Cited by 95
PEG–Ara-C conjugates for controlled release
Schiavon, O., Pasut, G., Moro, S., Orsolini, P., Guiotto, A., & Veronese, F. M. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.10.005 · Cited by 95
MCLEOD, A., FRIEND, D., & Tozer, T. N. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90269-l · Cited by 88
Hyperbranched Polymer-Drug Conjugates with High Drug Payload for Enhanced Cellular Delivery
Kolhe, P., Khandare, J. J., Pillai, O., Kannan, S., Lieh-Lai, M. W., & Kannan, R. M. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7670-x · Cited by 85
Self-citationRecent advances in drug delivery systems
(1985) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(85)90031-x · Cited by 83
Introduction to “Dendrimers and Dendritic Polymers”
Tomalia, D. A., & Fréchet, J. M. J. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.03.003 · Cited by 80
Prodrugs of Peptides and Proteins for Improved Formulation and Delivery
Oliyai, R., & Stella, V. J. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.002513 · Cited by 79
Characterization of Site-Specific ScFv PEGylation for Tumor-Targeting Pharmaceuticals
Natarajan, A., Xiong, C.-Y., Albrecht, H., DeNardo, G. L., & DeNardo, S. J. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0498121 · Cited by 73
Differences in the intracellular fate of free and polymer-bound doxorubicin
Hovorka, O., Šťastný, M., Etrych, T., Šubr, V., Strohalm, J., Ulbrich, K., & Říhová, B. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00016-0 · Cited by 72
Yura, H., Yoshimura, N., HAMASHIMA, T., Akamatsu, K., Nishikawa, M., Takakura, Y., & Hashida, M. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00150-3 · Cited by 61
Soluble macromolecular carriers for the delivery of antitumour drugs
Sezaki, H., Takakura, Y., & Hashida, M. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90013-6 · Cited by 57
Rosowsky, A., Forsch, R. A., Uren, J. R., & Wick, M. M. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00144a016 · Cited by 56
Gunaseelan, S., Debrah, O., Wan, L., Leibowitz, M. J., Rabson, A. B., Stein, S., & Sinko, P. J. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0498875 · Cited by 47
Synthesis of Tailor-Made Soluble Polymeric Drug Carriers
Kopec̆ek, J. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2745-5_4 · Cited by 37
New derivatives of polyglutamic acid as drug carrier systems
Hoste, K., Schacht, E. H., & Seymour, L. W. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00142-x · Cited by 34
Somack, R., Saifer, M. G. P., & Williams, L. D. (1991) · Free Radical Research Communications · doi:10.3109/10715769109145830 · Cited by 32
Kunath, K., Kopečková, P., Minko, T., & Kopec̆ek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00033-8 · Cited by 31
Self-citationThe road from poly(α-amino acids) to the prediction of protein conformation
Fasman, G. D. (1987) · Biopolymers · doi:10.1002/bip.360260009 · Cited by 29
Effect of the Chemical Modification of Dextran on the Degradation by Rat Liver Lysosomal Enzymes
Vercauteren, R., Schacht, E. H., & Duncan, R. (1992) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159200700404 · Cited by 29
Synthesis and evaluation of macromolecular prodrugs of mitomycin C
Marre, A. D., Soyez, H., Schacht, E. H., Shoaibi, M. A., Seymour, L. W., & Říhová, B. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00058-g · Cited by 26
Sund, M., Xu, L. L., Rahman, A., Qian, B., Hammarström, M., & Danielsson, Å. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02123.x · Cited by 18
Cited by
Hydrogels in controlled release formulations: Network design and mathematical modeling
Lin, C.-C., & Metters, A. T. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.004 · Cited by 1,768
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Polymers for Drug Delivery Systems
Liechty, W. B., Kryscio, D. R., Slaughter, B. V., & Peppas, N. A. (2010) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-073009-100847 · Cited by 1,608
The development of microgels/nanogels for drug delivery applications
Oh, J. K., Drumright, R., Siegwart, D. J., & Matyjaszewski, K. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2008.01.002 · Cited by 1,598
Herzberger, J., Niederer, K., Pohlit, H., Seiwert, J., Worm, M., Wurm, F. R., & Frey, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00441 · Cited by 865
Metadata
- Authors
- Khandare, J., & Minko, T.
- Venue
- Progress in Polymer Science
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 31
- Issue
- 4
- Pages
- 359-397
- ISSN
- 0079-6700 (ISSN-L)
- OpenAlex
- W2024714448
- Cited by
- 639
- References
- 91
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.